NYSE$ZBH

Zimmer Biomet Holdings Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Zimmer Biomet reported strong revenue growth and earnings per share.

Zimmer Biomet announced third quarter net sales of $1.754 billion, an increase of 5.0% over the prior year period, and an increase of 4.7% on a constant currency basis. Diluted earnings per share were $0.77 for the third quarter, and adjusted diluted earnings per share were $1.65.

  • Third quarter net sales of $1.754 billion increased 5.0% and 4.7% on a constant currency basis
  • Third quarter diluted earnings per share were $0.77; adjusted diluted earnings per share were $1.65
  • The Company updates 2023 reported revenue guidance due to currency expectations and reaffirms 2023 constant currency revenue growth and adjusted earnings per share financial guidance
  • Appointment of Ivan Tornos as President and Chief Executive Officer

Headline financials

Total Revenue

$1.75B

Previous: $1.67B+5.0%
EPS (adj)

$1.65

Previous: $1.58+4.4%
Capital Expenditures

-$228M

Previous: -$125M-83.4%
Free Cash Flow

-$65.6M

Previous: $69.5M-194.4%
Net Income

$163M

Previous: $194M-16.1%
Operating Income

$267M

Previous: $245M+8.7%
Gross Profit

$1.24B

Previous: $1.18B+4.5%
Cash & Equivalents

$292M

Previous: $545M-46.4%
Total Assets

$21.2B

Previous: $21.3B-0.5%
Stock-Based Comp

$15.6M

Previous: $27.4M-43.1%

Revenue & EPS history

Zimmer Biomet · Revenue · Quarterly

$1.75B

Q3 2023+5%vs Q3 2022
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Zimmer Biomet · $1.59B total across 3 segments · Q3 2023

  • Knees Net Sales
    $706M+7.5%
  • Hips Net Sales
    $465M-0.6%
  • S.E.T. Net Sales
    $423M+3.4%

Forward guidance

The Company is updating its full-year 2023 financial guidance to modify the expected foreign currency exchange impact and is reaffirming constant currency revenue growth as well as adjusted EPS guidance

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-0.4%

Avg return

Earnings day

-1.7%

Avg return

5 days after

-2.3%

Avg return

30 days after

42%

30 / 72 earnings

Positive

+11.9%

Q3 2020

Best reaction

-15.3%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.1%-10.5%-11.5%
Q4 2025+1.9%+7.5%+3.2%
Q3 2025-15.2%-14.0%-8.6%
Q1 2025-11.6%-7.0%-10.7%
Q4 2024-5.1%-8.6%-0.2%
Q3 2024+2.9%+4.4%+7.9%
Q2 2024-0.8%-2.3%-4.3%
Q1 2024+1.8%+1.6%-3.7%
Q4 2023-3.7%-3.4%-0.6%
Q3 2023-4.1%-3.5%+7.3%
Q2 2023-7.1%-8.6%-13.8%
Q1 2023+0.6%-0.7%-8.3%
Q4 2022+0.9%+2.6%-0.9%
Q3 2022-5.7%-3.9%+10.0%
Q2 2022+5.3%+3.2%-2.7%
Q1 2022+4.7%-0.3%+1.2%
Q4 2021-2.4%-5.4%-1.4%
Q3 2021-4.8%-9.7%-18.5%
Q2 2021-9.1%-8.6%-8.5%
Q1 2021-2.5%-3.1%-10.1%
Q4 2020-0.6%-0.2%-1.4%
Q3 2020+11.9%+7.2%+7.0%
Q2 2020-1.5%+2.7%+3.5%
Q1 2020-6.8%-7.8%+10.2%
Q4 2019+6.2%+5.3%-13.0%
Q3 2019+4.9%+5.5%+8.1%
Q2 2019+8.6%+9.1%+7.9%
Q1 2019-3.1%-2.8%-8.2%
Q4 2018+7.8%+7.9%+14.5%
Q3 2018-5.6%-7.0%-7.7%
Q2 2018+8.0%+7.1%+7.1%
Q1 2018+5.7%+5.8%+0.4%
Q4 2017-0.2%-1.3%-10.9%
Q3 2017-7.7%-10.1%-5.8%
Q2 2017-3.8%-6.5%-12.1%
Q1 2017-4.5%-3.7%-4.9%
Q4 2016+2.7%+2.4%+2.3%
Q3 2016-15.3%-15.9%-16.9%
Q2 2016+6.9%+6.4%+5.6%
Q1 2016-0.1%
Q4 2015-2.3%
Q3 2015+6.8%
Q2 2015-2.7%
Q1 2015-4.3%
Q4 2014-2.1%
Q3 2014+5.1%
Q2 2014-2.3%
Q1 2014+9.9%
Q4 2013+0.8%
Q3 2013-3.3%
Q2 2013+0.5%
Q1 2013+0.6%
Q4 2012-1.3%
Q3 2012+2.0%
Q2 2012-3.5%
Q1 2012-0.6%
Q4 2011-1.3%
Q3 2011+3.7%
Q2 2011-5.6%
Q1 2011+0.5%
Q4 2010+2.2%
Q3 2010+3.6%
Q2 2010-1.5%
Q1 2009-0.8%
Q1 2010+1.6%
Q4 2009-0.2%
Q3 2009+4.0%
Q3 2008+4.0%
Q4 2007-1.0%
Q2 2008-1.0%
Q2 2009-1.0%
Q4 2008-1.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro